Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

HealthLinc Medical to distribute B-TEMIA’s walking assistance device in British Columbia

HealthLinc Medical Equipment (dba HME Mobility & Accessibility) has agreed to distribute B-TEMIA's Keeogo powered walking assistance device in British Columbia.

Stéphane Bédard, Founder and CEO of B-TEMIA, said: "B-TEMIA is proud to partner with HME Mobility & Accessibility which has a long history of servicing home users for their mobility and accessibility needs. With HME, we will now be able to make available our acquisition process of the Keoogo™ to potential customers who have been asking for a point of sale in B.C.

"Moreover, this partnership represents a key milestone in our strategic expansion in the Canadian market."

Cameron Fleming, one of HME's two principals, said: "On behalf of management and staff at HME Mobility and Accessibility, it gives me great pride to announce our ground-breaking partnership agreement with B-TEMIA as we introduce Keeogo™ to British Columbia.

"The founders and developers at B-TEMIA are justly proud of their wonderful technology and outstanding products, and similarly we at HME are extremely pleased to be able to offer Keeogo™ to our many clients, both new and long-standing."

About Keeogo

Keeogo is a powered walking assistance device developed by B-TEMIA. It has been used by individuals with degenerative medical conditions such as knee/hip osteoarthritis, multiple sclerosis, Parkinson's disease, stroke, incomplete spinal cord injury (SCI) and other conditions that limit mobility.

Used as rehabilitation equipment or as a daily commodity for walking, Keeogo is commercially available for purchase or rental in Canada. It is currently under investigation in a multicenter pivotal clinical trial aiming for Food and Drug Administration (FDA) clearance, a prerequisite to enter the US market.